BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD 3.040
-0.050 (-1.62%)
Jun 10, 2026, 3:59 PM EST
BioRem Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4.98 | 4.82 | 3.04 | 2.18 | 1.61 | 1.3 |
Depreciation & Amortization | 0.43 | 0.47 | 0.47 | 0.38 | 0.35 | 0.34 |
Stock-Based Compensation | 0.04 | 0.06 | 0.14 | 0.13 | 0.09 | 0.01 |
Other Adjustments | 0.7 | 0.65 | 0.47 | 0.54 | 0.12 | 0.43 |
Change in Receivables | -2.64 | -0.64 | 0.24 | -3.04 | -1.72 | -2.53 |
Changes in Inventories | 0.87 | 1.42 | -1.83 | -0.04 | 0.25 | 0.04 |
Changes in Accounts Payable | 1.7 | 4.13 | -2.52 | 1.38 | 0.74 | 3.25 |
Changes in Accrued Expenses | -0.1 | -0.56 | 0.23 | -0.46 | 0.06 | 0.32 |
Changes in Income Taxes Payable | -0.07 | -0.07 | 0.75 | -0.7 | 0.35 | 0.3 |
Changes in Unearned Revenue | -1.91 | -1.7 | 1.84 | 1.81 | -0.55 | 0.24 |
Changes in Other Operating Activities | -2.18 | -0.93 | 0.84 | -1.69 | 0.14 | 0.06 |
Operating Cash Flow | 1.81 | 7.64 | 3.69 | 0.49 | 1.44 | 3.78 |
Operating Cash Flow Growth | -56.83% | 107.28% | 652.01% | -66.09% | -61.79% | 13.11% |
Capital Expenditures | -0.55 | -0.37 | -0.37 | -0.55 | -0.2 | -0.08 |
Investing Cash Flow | -0.55 | -0.37 | -0.37 | -0.55 | -0.2 | -0.08 |
Short-Term Debt Issued | - | - | - | - | - | 1.01 |
Short-Term Debt Repaid | - | - | - | -0.78 | -0.23 | - |
Net Short-Term Debt Issued (Repaid) | - | - | - | -0.78 | -0.23 | 1.01 |
Long-Term Debt Issued | - | - | - | - | - | 4 |
Long-Term Debt Repaid | -0.58 | -0.57 | -0.55 | -0.53 | -0.5 | - |
Net Long-Term Debt Issued (Repaid) | -0.58 | -0.57 | -0.55 | -0.53 | -0.5 | 4 |
Issuance of Common Stock | 0.02 | 0.02 | 0.16 | 0.07 | 0 | 0.08 |
Repurchase of Common Stock | - | -0.1 | - | - | - | -12.41 |
Net Common Stock Issued (Repurchased) | 0.02 | -0.08 | 0.16 | 0.07 | 0 | -12.33 |
Other Financing Activities | -0.08 | -0.11 | -0.18 | -0.1 | -0.22 | -0.24 |
Financing Cash Flow | -0.75 | -0.77 | -0.57 | -1.33 | -0.95 | -7.56 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.13 | -0.21 | 0.18 | -0.09 | -0.99 | -0.55 |
Net Cash Flow | 0.39 | 6.29 | 2.92 | -1.48 | -0.7 | -4.4 |
Free Cash Flow | 1.27 | 7.27 | 3.31 | -0.06 | 1.24 | 3.71 |
Free Cash Flow Growth | -82.59% | 119.45% | - | - | -66.50% | 23.48% |
FCF Margin | 2.85% | 17.17% | 8.85% | -0.25% | 4.30% | 15.14% |
Free Cash Flow Per Share | 0.08 | 0.39 | 0.18 | -0.00 | 0.07 | 0.10 |
Levered Free Cash Flow | 2.59 | 6.63 | 1.92 | 1 | 2.01 | 10.8 |
Unlevered Free Cash Flow | 3.28 | 7.33 | 2.61 | 2.52 | 2.92 | 5.82 |